More Than Blood Sugar: Molecular Hydrogen and the Biology of Diabetes

By Sarah Taylor 15 min read
More Than Blood Sugar: Molecular Hydrogen and the Biology of Diabetes

Blood glucose has become something people can monitor almost continuously. Once largely confined to medical settings and diabetes management, continuous glucose monitors have increasingly entered the consumer wellness market, allowing people without diabetes to track how their glucose levels respond to meals, exercise, sleep, and other everyday activities. In March 2024, the U.S. Food and Drug Administration (FDA) cleared the first over-the-counter continuous glucose monitor, and by 2026, these devices had become part of a growing wellness trend promoted by social media influencers, athletes, and celebrities. Yet this growing interest in glucose monitoring exists alongside a striking public health problem. According to the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes in 2024, while an estimated 252 million, or nearly 43%, were unaware they had the condition.

The contrast highlights an important distinction between measuring glucose and understanding the metabolic processes responsible for regulating it. Blood glucose concentrations provide essential information about diabetes, but they represent only one part of a system involving multiple organs and tissues. Under normal conditions, insulin released by the pancreas helps coordinate the movement, use, and storage of nutrients. Skeletal muscle takes up glucose from the circulation, the liver adjusts its production and storage of glucose, and adipose tissue regulates the storage and release of fatty acids. These processes operate together to maintain metabolic stability as nutrient availability and physiological demands change.

In type 2 diabetes (T2D), this coordination becomes progressively impaired. Skeletal muscle, liver, and adipose tissue can become less responsive to insulin, a condition known as insulin resistance. Initially, pancreatic β-cells may compensate by producing more insulin, allowing blood glucose to remain relatively controlled even as the underlying metabolic demands increase. Over time, however, insulin secretion may become insufficient to overcome that resistance, contributing to the persistent hyperglycemia that characterizes diabetes. Altered lipid metabolism, inflammatory signaling, mitochondrial dysfunction, and oxidative stress can further interfere with insulin action and β-cell function, creating interactions that may progressively impair metabolic regulation.

The consequences also extend beyond the tissues responsible for controlling blood glucose. Prolonged hyperglycemia can alter cellular metabolism and increase the formation of reactive oxygen species (ROS) and advanced glycation end products, contributing to inflammatory activity and impaired vascular function. These processes help explain why diabetes can affect seemingly unrelated tissues, including the blood vessels of the retina, the kidneys, peripheral nerves, and the cardiovascular system. Importantly, ROS and inflammatory mediators are not inherently harmful. They also participate in normal cellular signaling and tissue responses, making the loss of their regulation more consequential than their presence alone. Diabetes therefore involves more than the accumulation of excess glucose in the bloodstream. It can progressively alter the conditions under which cells maintain their function, respond to metabolic demands, and withstand injury.

Some consequences may also persist beyond the period of elevated glucose exposure. Long-term follow-up of the Diabetes Control and Complications Trial, involving people with type 1 diabetes (T1D), demonstrated that the benefits of earlier intensive glucose management continued even after average glucose control became similar between treatment groups. This phenomenon, known as metabolic memory, illustrates how earlier glucose exposure can influence the subsequent risk of complications. Although these findings were established in type 1 diabetes, they reinforce a broader distinction between controlling glucose concentrations and understanding the biological consequences of prolonged metabolic disturbances.

These relationships have important implications for how diabetes is studied and managed. Controlling blood glucose remains essential, but the condition of individual tissues also depends on how they respond to inflammatory challenges, regulate oxidative activity, maintain mitochondrial function, and repair accumulated damage. These processes are closely connected to the metabolic disturbances accompanying diabetes, yet they cannot be fully described by a glucose measurement alone. They have consequently become important areas of investigation for understanding diabetic complications and identifying additional ways to influence the cellular responses associated with metabolic disease.

One molecule being investigated for its effects on these responses is molecular hydrogen (H₂). Although hydrogen is familiar as a component of water, molecular hydrogen is different from the hydrogen atoms chemically bound within a water molecule. H₂ is a small, colorless gas consisting of two hydrogen atoms, and it is not entirely foreign to human biology. Intestinal microorganisms naturally produce H₂ during the fermentation of dietary material, making it part of the complex chemical environment of the gastrointestinal tract. Biomedical researchers have investigated additional H₂ exposure through several methods, particularly inhalation and the consumption of water containing dissolved hydrogen gas, commonly called hydrogen-rich water. Experimental studies have also used saline solutions containing dissolved H₂, including direct application to injured tissues

Interest in H₂ expanded considerably after a 2007 study reported that hydrogen gas reduced oxidative injury in cultured cells and limited brain damage following experimentally induced ischemia and reperfusion in rats. The investigators initially attributed these effects to the ability of H₂ to react with highly damaging hydroxyl radicals, while leaving other reactive molecules involved in normal physiological signaling relatively unaffected. Subsequent research has suggested a more complex biological picture involving changes in redox-sensitive signaling, inflammatory pathways, and mitochondrial responses. In 2025, for example, researchers demonstrated that H₂ altered the activity of mitochondrial respiratory-chain Complex III and activated an adaptive mitochondrial stress response through changes involving the Rieske iron–sulfur protein. Although the precise initiating mechanisms remain under investigation, these findings suggest that H₂ may influence cellular regulation rather than functioning simply as a conventional antioxidant.

These effects are particularly relevant to the biology of diabetes because insulin resistance, impaired cellular metabolism, inflammatory signaling, and oxidative stress participate in both metabolic dysfunction and the development of complications. The experimental evidence raises the possibility that H₂ could influence some of these interconnected processes, although modifying a biological pathway does not necessarily translate into improved glucose control or reduced disease risk. Human investigations have therefore begun to examine metabolic outcomes more directly, with findings that are encouraging in some studies but inconsistent across the available evidence.

One of the earliest human investigations examined hydrogen-rich water in 30 people with type 2 diabetes and six with impaired glucose tolerance. In this randomized, double-blind crossover study, eight weeks of hydrogen-rich water reduced modified low-density lipoprotein (LDL), small dense LDL, and urinary 8-isoprostanes, a marker of lipid peroxidation. Glucose tolerance also normalized in four of the six participants with impaired glucose tolerance, although the study did not demonstrate significant overall improvements in fasting glucose or HbA1c. The findings were therefore more consistent for markers of lipid metabolism and oxidative stress than for conventional measures of glycemic control.

Subsequent research has produced additional evidence of metabolic effects. In a randomized controlled trial involving 60 adults with metabolic syndrome, 24 weeks of hydrogen-rich water reduced fasting glucose accompanied by a reduction in HbA1c and improvements in several lipid and inflammatory measurements compared with placebo. Although the participants were not specifically recruited for established diabetes, the findings suggested that H₂ could influence several metabolic abnormalities that commonly develop alongside insulin resistance. A separate randomized trial involving 73 people with impaired fasting glucose found that eight weeks of hydrogen-rich water produced a modest additional improvement in fasting glucose compared with ordinary water. Researchers also observed changes in intestinal microbial populations and associations with circulating metabolites, suggesting another possible connection between H₂ and metabolic regulation, although the microbiome analyses did not establish a causal mechanism.

However, improvements have not been consistent across controlled studies. A multicenter, double-blind randomized trial involving 50 people with type 2 diabetes examined whether three months of electrolyzed hydrogen-rich water could improve insulin resistance, measured using the homeostasis model assessment of insulin resistance (HOMA-IR). The investigators found no significant difference in the primary outcome between the hydrogen-rich water and control groups. Although circulating lactate decreased in the hydrogen group and was associated with several metabolic measurements, these secondary findings did not establish an overall improvement in insulin resistance.

Larger observational studies have reported more favorable glycemic findings, although their designs introduce additional uncertainty. In a six-month retrospective study involving 1,088 adults with type 2 diabetes, patients receiving hydrogen inhalation alongside conventional treatment experienced an HbA1c reduction compared with matched patients receiving conventional treatment alone. Fasting glucose and several measures of lipid metabolism and insulin resistance also improved more in the hydrogen group. However, because treatment was not randomly assigned, differences in patient characteristics, clinical management, or other unmeasured factors could have contributed to the results.

Taken together, these studies indicate that H₂ can be associated with measurable changes in glucose and metabolic markers, but they do not establish a consistent glucose-lowering effect in people with type 2 diabetes. The studies also differ in intervention duration, hydrogen concentration, administration route, and the metabolic characteristics of their participants, making direct comparisons difficult. Nevertheless, experimental findings may offer some insight into how H₂ might influence metabolic function, particularly in tissues directly involved in glucose regulation.

Experimental research in animal models and cell cultures suggests that H₂ may influence glucose regulation through several mechanisms. In cultured muscle cells, H₂ increased glucose uptake, while animal experiments showed improved glucose control in a model of type 1 diabetes, although results were less pronounced in models of type 2 diabetes. In obese diabetic mice, hydrogen-rich water also reduced glucose, insulin, and triglycerides while influencing liver pathways involved in metabolic regulation. These findings suggest that H₂ can affect aspects of glucose metabolism, although their relevance to human diabetes remains uncertain.

Other experiments have investigated whether H₂ can influence the tissue damage associated with diabetes. In diabetic mice, hydrogen-rich water improved the ability of retinal blood vessels to respond to changing conditions, even though blood glucose remained elevated. Earlier research in diabetic rats also found reductions in retinal swelling, vascular leakage, and cell death. Similarly, hydrogen treatment improved nerve conduction and reduced oxidative damage in diabetic rats, suggesting possible effects on processes involved in diabetic neuropathy. Although these results remain preclinical, they suggest that H₂ may influence tissue function as well as glucose metabolism.

Wound healing provides another example. Diabetes can impair circulation, inflammatory regulation, and tissue repair, contributing to wounds that heal slowly or remain open. In diabetic rats, topical hydrogen-enriched water improved wound-healing outcomes. More recently, a randomized study involving 60 patients with diabetic foot ulcers found that hydrogen-rich saline irrigation improved early healing measurements compared with ordinary saline, although absolute wound area did not differ significantly after seven days. Accompanying laboratory experiments also identified effects on blood-vessel formation and mitochondrial maintenance, suggesting possible mechanisms through which H₂ could influence tissue repair.

These findings extend the potential relevance of H₂ beyond glucose regulation to the cellular processes involved in diabetic complications. However, differences in administration methods, experimental models, and measured outcomes make direct comparisons difficult. In addition, improvements in tissue function may partly reflect better glucose regulation rather than direct effects of H₂ on the affected tissues. Most evidence for diabetic complications remains preclinical, and larger human trials are needed to establish whether these effects translate into meaningful health benefits.

Established diabetes management continues to depend on glucose control, cardiovascular and kidney risk reduction, and the prevention and treatment of complications. Molecular hydrogen has not been established as a treatment for diabetes or a substitute for these approaches. Nevertheless, research into its effects on glucose metabolism, vascular function, nerve health, and tissue repair suggests several directions for further investigation. Blood glucose remains an essential measure of diabetes, but the condition of the tissues exposed to prolonged metabolic stress also matters. Understanding how H₂ might influence those responses could help clarify its potential role in diabetes research.

 

References

·         American Diabetes Association. (n.d.). Standards of care in diabetes. https://professional.diabetes.org/standards-of-care

·         Amitani, H., Asakawa, A., Cheng, K., Amitani, M., Kaimoto, K., Nakano, M., Ushikai, M., Li, Y., Tsai, M., Li, J. B., Terashi, M., Chaolu, H., Kamimura, R., & Inui, A. (2013). Hydrogen improves glycemic control in type1 diabetic animal model by promoting glucose uptake into skeletal muscle. PloS one, 8(1), e53913. https://doi.org/10.1371/journal.pone.0053913

·         Burgess, J. L., Wyant, W. A., Abdo Abujamra, B., Kirsner, R. S., & Jozic, I. (2021). Diabetic Wound-Healing Science. Medicina (Kaunas, Lithuania), 57(10), 1072. https://doi.org/10.3390/medicina57101072

·         Deniz, M., Akkuş, Y., Yıldız, G., Havadar, H. B., & Makav, M. (2026). Effect of hydrogen-enriched water on healing of excisional full-layer skin wounds in diabetic and non-diabetic rats. Naunyn-Schmiedeberg's archives of pharmacology, 399(1), 561–580. https://doi.org/10.1007/s00210-025-04427-x

·         Genitsaridi, I., Salpea, P., Salim, A., Sajjadi, S. F., Tomic, D., James, S., Thirunavukkarasu, S., Issaka, A., Chen, L., Basit, A., Luk, A. O. Y., Ma, R. C. W., Mbanya, J. C., Ramachandran, A., Wild, S. H., Duncan, B. B., Boyko, E. J., & Magliano, D. J. (2026). 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. The lancet. Diabetes & endocrinology, 14(2), 149–156. https://doi.org/10.1016/S2213-8587(25)00299-2

·         Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation research, 107(9), 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545

·         Hammad H. (2026). The wellness inspired rise of continuous glucose monitors for people without diabetes, including those with metabolic disorders. BMJ (Clinical research ed.), 392, s441. https://doi.org/10.1136/bmj.s441

·         Han, X. C., Ye, Z. H., Hu, H. J., Sun, Q., & Fan, D. F. (2023). Hydrogen exerts neuroprotective effects by inhibiting oxidative stress in experimental diabetic peripheral neuropathy rats. Medical gas research, 13(2), 72–77. https://doi.org/10.4103/2045-9912.345171

·         Jin, J., Yue, L., Du, M., Geng, F., Gao, X., Zhou, Y., Lu, Q., & Pan, X. (2025). Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application. MedComm, 6(5), e70194. https://doi.org/10.1002/mco2.70194

·         Kajiyama, S., Hasegawa, G., Asano, M., Hosoda, H., Fukui, M., Nakamura, N., Kitawaki, J., Imai, S., Nakano, K., Ohta, M., Adachi, T., Obayashi, H., & Yoshikawa, T. (2008). Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutrition research (New York, N.Y.), 28(3), 137–143. https://doi.org/10.1016/j.nutres.2008.01.008

·         Kamimura, N., Nishimaki, K., Ohsawa, I., & Ohta, S. (2011). Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity (Silver Spring, Md.), 19(7), 1396–1403. https://doi.org/10.1038/oby.2011.6

·         Lachin, J. M., Nathan, D. M., & DCCT/EDIC Research Group (2021). Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes care, 44(10), 2216–2224. https://doi.org/10.2337/dc20-3097

·         LeBaron, T. W., Singh, R. B., Fatima, G., Kartikey, K., Sharma, J. P., Ostojic, S. M., Gvozdjakova, A., Kura, B., Noda, M., Mojto, V., Niaz, M. A., & Slezak, J. (2020). The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial. Diabetes, metabolic syndrome and obesity : targets and therapy, 13, 889–896. https://doi.org/10.2147/DMSO.S240122

·         Liang, B., Shi, L., Du, D., Li, H., Yi, N., Xi, Y., Cui, J., Li, P., Kang, H., Noda, M., Sun, X., Liu, J., Qin, S., & Long, J. (2023). Hydrogen-Rich Water Ameliorates Metabolic Disorder via Modifying Gut Microbiota in Impaired Fasting Glucose Patients: A Randomized Controlled Study. Antioxidants (Basel, Switzerland), 12(6), 1245. https://doi.org/10.3390/antiox12061245

·         Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024). Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal transduction and targeted therapy, 9(1), 262. https://doi.org/10.1038/s41392-024-01951-9

·         Negishi, S., Ito, M., Hasegawa, T., Otake, H., Ohkawara, B., Masuda, A., Mino, H., LeBaron, T. W., & Ohno, K. (2025). The Rieske iron-sulfur protein is a primary target of molecular hydrogen. Redox biology, 88, 103952. https://doi.org/10.1016/j.redox.2025.103952

·         Ogawa, S., Ohsaki, Y., Shimizu, M., Nako, K., Okamura, M., Kabayama, S., Tabata, K., Tanaka, Y., & Ito, S. (2021). Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial. Diabetology international, 13(1), 209–219. https://doi.org/10.1007/s13340-021-00524-3

·         Ohsawa, I., Ishikawa, M., Takahashi, K., Watanabe, M., Nishimaki, K., Yamagata, K., Katsura, K., Katayama, Y., Asoh, S., & Ohta, S. (2007). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature medicine, 13(6), 688–694. https://doi.org/10.1038/nm1577

·         Sugiyama, R., Hanaguri, J., Yokota, H., Kushiyama, A., Kushiyama, S., Kikuchi, T., Igarashi, T., Iketani, M., Ohsawa, I., Harino, S., Nakashizuka, H., Yamagami, S., & Nagaoka, T. (2024). Oral Intake of Hydrogen Water Improves Retinal Blood Flow Dysregulation in Response to Flicker Stimulation and Systemic Hyperoxia in Diabetic Mice. Translational vision science & technology, 13(10), 36. https://doi.org/10.1167/tvst.13.10.36

·         Teufel, F., Orgutsova, K., Genitsaridi, I., Carrillo-Larco, R. M., Varghese, J. S., Marcus, M. E., Sacre, J. W., Sajjadi, S. F., Chiwanga, F., Manne-Goehler, J., Seiglie, J., Flood, D., Harding, J., Salpea, P., Salim, A., Boyko, E. J., Magliano, D. J., & Ali, M. K. (2026). Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas. Diabetes care, 49(3), 490–496. https://doi.org/10.2337/dc25-2583

·         U.S. Food and Drug Administration. (2024, March 5). FDA clears first over-the-counter continuous glucose monitor [Press release]. https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor

·         Welsh, C., Cabotaje, P. R., Marcelino, V. R., Watts, T. D., Kountz, D. J., Jespersen, M., Gould, J. A., Doan, N. Q., Lingford, J. P., Koralegedara, T., Solari, J., D'Adamo, G. L., Huang, P., Bong, N., Gulliver, E. L., Young, R. B., Land, H., Walter, K., Cann, I., Pereira, G. V., … Greening, C. (2025). A widespread hydrogenase supports fermentative growth of gut bacteria in healthy people. Nature microbiology, 10(11), 2686–2701. https://doi.org/10.1038/s41564-025-02154-w

·         Xiao, X., Cai, J., Xu, J., Wang, R., Cai, J., Liu, Y., Xu, W., Sun, X., & Li, R. (2012). Protective effects of hydrogen saline on diabetic retinopathy in a streptozotocin-induced diabetic rat model. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 28(1), 76–82. https://doi.org/10.1089/jop.2010.0129

·         Xu, Z., Cui, X., Chu, H., Wan, H., Xie, Y., Wang, Y., Ni, Q., Ding, X., & Song, G. (2026). Hydrogen-Enriched Hyaluronic Acid Dressing Ameliorates Diabetic Foot Ulcer via Promoting Mitophagy. Journal of diabetes, 18(4), e70209. https://doi.org/10.1111/1753-0407.70209

·         Zhao, Z., Ji, H., Zhao, Y., Liu, Z., Sun, R., Li, Y., & Ni, T. (2023). Effectiveness and safety of hydrogen inhalation as an adjunct treatment in Chinese type 2 diabetes patients: A retrospective, observational, double-arm, real-life clinical study. Frontiers in endocrinology, 13, 1114221. https://doi.org/10.3389/fendo.2022.1114221

Share
Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.